Plain-English translation of NCT06463808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a medication called (rhBNP) to see if it can help your heart recover after a front-wall heart attack. You would receive this medication intravenously (through an IV) for 3 days after your emergency heart procedure. Researchers want to learn whether this treatment can reduce harmful changes to your heart's structure and improve how well it pumps blood.
When a heart attack damages the front wall of your heart, the organ can develop permanent changes that make it weaker over time. This medication may help prevent or reduce that damage, and doctors want to test whether it truly makes a difference in patient outcomes.
If you join this study, you'll be randomly assigned to receive either the new medication or a placebo (inactive treatment) through an IV for 3 days after your emergency heart procedure. Both groups will receive standard care for heart attack recovery. You'll then have follow-up visits over 24 weeks where doctors will perform heart ultrasounds and blood tests to measure how your heart is healing and whether the medication helped.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China